Abstract
Severe acute respiratory syndrome (SARS) is a newly emerged infection that is caused by a previously unrecognized virus–a novel coronavirus designated as SARS-associated coronavirus (SARS-CoV). From November 2002 to July 2003 the cumulative number of worldwide cases was >8000, with a mortality rate of close to 10%. The mortality has been higher in older patients and those with co-morbidities. SARS has been defined using clinical and epidemiological criteria and cases are considered laboratory-confirmed if SARS coronavirus is isolated, if antibody to SARS coronavirus is detected, or a polymerase chain reaction test by appropriate criteria is positive. At the time of writing (24 May 2004), no specific therapy has been recommended. A variety of treatments have been attempted, but there are no controlled data. Most patients have been treated throughout the illness with broad-spectrum antimicrobials, supplemental oxygen, intravenous fluids, and other supportive measures. Transmission of SARS is facilitated by close contact with patients with symptomatic infection. The majority of cases have been reported among healthcare providers and family members of SARS patients. Since SARS-CoV is contagious, measures for prevention center on avoidance of exposure, and infection control strategies for suspected cases and contacts. This includes standard precautions (hand hygiene), contact precautions (gowns, goggles, gloves) and airborne precautions (negative pressure rooms and high efficiency masks). In light of reports of new cases identified during the winter of 2003–4 in China, it seems possible that SARS will be an important cause of pneumonia in the future, and the screening of outpatients at risk for SARS may become part of the pneumonia evaluation.
Article PDF
Similar content being viewed by others
References
Peiris JSM, Phil D, Yuen KY, et al. The severe acute respiratory syndrome. N Engl J Med 2003; 349: 2431–41
Tsang KW, Lam WK. Management of severe acute respiratory syndrome: the Hong Kong University experience. Am J Respir Crit Care Med 2003; 68(4): 417–24
WHO. Case definitions for surveillance of Severe Acute Respiratory Syndrome SARS) [online]. Available from URL: http://www.who.int/csr/sars/casedefini-tion/htm [Accessed 2004 May 20]
Center for Disease Control and Prevention. Updated interim US case definition of Sever Acute Respiratory Syndrome (SARS) [online]. Available from URL: http:/www.cdc.gov/ncidod/sars/casedefinition/htm [Accessed 2004 May 20]
Center for Disease Control and Prevention. Revised US Surveillance case definition for Severe Acute Respiratory Syndrome (SARS) and update on SARS cases: United States and Worldwide, 2003 Dec. Morb Mortal Wkly Rep 2003; 52: 1202–6
Ksiazek TG, Erdman D, Goldsmith C, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1953–66
Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1967–76
Peiris JSM, Lai ST, Poon LLM, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003 Apr 19; 361(9366): 1319–25
Guan YU, Zheng BJ, He YQ, et al. Isolation and characterization of viruses related the SARS coronavirus from animals in southern China. Science 2003; 302: 276–8
Fouchier RAM, Kuiken T, Schutten M, et al. Koch’s postulates fulfilled for SARS virus [brief communication]. Nature 2003; 423: 240
Stavrinides J, Guttman DS. Mosaic evolution of the severe acute respiratory syndrome coronavirus. J Virol 2004; 78: 76–82
WHO. Cumulative number of reported probable cases of SARS [online]. Available from URL: http://www.who.int/csr/sars/country/2003_07_ll/en/ [Accessed 2004 May 20]
WHO. Summary of probable SARS cases with onset of illness to July 2003 [online]. Available from URL: www.who.int/csr/sars/country/ta-ble2004_04_21/en [Accessed 2004 May 16]
Center for Disease Control and Prevention. Update: outbreak of severe acute respiratory syndrome: worldwide, 2003. Morb Mortal Wkly Rep 2003; 52(12): 243
Hui DSC, Sung JJY. Severe acute respiratory syndrome. Chest 2003; 124: 12–5
Chan JWM, Ng CK, Chan YH, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 2003; 58: 686–9
Peiris JSM, Chu CM, Cheng VCC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003; 361: 1767–72
Center for Disease Control and Prevention. SARS in Taiwan [online]. http://www.cdc.gov/ncidod/dars/Taiwan17Dec2003.htm [Accessed 2004 May 20]
Center for Disease Control and Prevention. Recent SARS cases in China [online]. http://www.cdc.gov/ncidod/sars/han/sarsfluhanjanl404.htm [Accessed 2004 May 20]
Center for Disease Control and Prevention. China reports ninth recent possible SARS case [online]. http://www.cdc.gov/ncidod/sars/han/china29apr2004.htm [Accessed 2004 May 20
Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003 May 15; 348(20): 1977–85
Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003 May 15; 348(20): 1995–2005
Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003 May 15; 348(20): 1986–94
Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto Area. JAMA 2003; 289: 2801–9
Center for Disease Control and Prevention. Outbreak of severe acute respiratory syndrome: worldwide, 2003. MMWR Morb Mortal Wkly Rep 2003; 52: 226–8
Lam MF, Ooi GC, Lam B, et al. An indolent case of severe acute respiratory syndrome. Am J Respir Crit Care Med 2004; 169(1): 125–8
Vu HT, Leitmeyer KC, Le DH, et al. Clinical description of a completed outbreak of SARS in Vietnam, February-May 2003. Emerg Infect Dis 2004; 10: 334–8
Ooi CG, Khong PL, Ho JC, et al. Severe acute respiratory syndrome: radiographic evaluation and clinical outcome measures. Radiology 2003; 229(2): 500–6
Muller NL, Ooi GC, Khong PL, et al. High-resolution CT findings of severe acute respiratory syndrome at presentation and after admission. AJR Am J Roentgenol 2004; 182(1): 39–44
Rainer TH, Cameron PA, Smit D, et al. Evaluation of WHO criteria for identifying patients with severe respiratory syndrome out of hospital: prospective observational study. BMJ 2003; 326: 1354–8
Center for Disease Control and Prevention. Severe Acute respiratory syndrome (SARS) and coronavirus testing: United States, 2003. Morb Mortal Wkly Rep 2003; 53: 297–302
Center for Disease Control and Prevention. Interpreting SARS-CoV test results from CDC and other public health laboratories [online]. Available from URL: http://www.cdc.gOv/ncidod/sars/guidance/F/pdf/app7.pdf [Accessed 2004 May 20]
Grant PR, Garson JA, Tedder RS. Detection of SARS coronavirus in plasma by real-time RT-PCR. N Engl J Med 2003; 349: 2468–9
Center for Disease Control and Prevention. Public Health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS) version 2 (January 8, 2004). Suppl. F: laboratory guidance [online]. Available from URL: http://www.cdc.gov/ncidod/sars.guidance/index.htm [Accessed 2004, May 20]
Ho JC, Ooi GC, Mok TY, et al. Tsang KW. High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med 2003; 168 (12): 1449–56
Oba Y. The use of corticosteroids in SARS. N Engl J Med 2003; 348(20): 2034–5
Knowles SR, Phillips EJ, Dresser L, et al. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Clin Infect Dis 2003; 37: 1139–42
Loutfy MR, Blatt LM, Siminovitch KA, et al. Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA 2003; 290: 3222–8
Sampathkumar P, Zelalem T, Smith TF, et al. SARS: epidemiology, clinical presentation, management, and infection control measures. Mayo Clin Proc 2003; 78: 882–90
Seto WH, Tsang D, Yung RW, et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003; 361: 1519–20
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
File, T.M., Tsang, K.W.T. Severe Acute Respiratory Syndrome. Treat Respir Med 4, 95–106 (2005). https://doi.org/10.2165/00151829-200504020-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151829-200504020-00003